↓ Skip to main content

How to select IgG subclasses in developing anti-tumor therapeutic antibodies

Overview of attention for article published in Journal of Hematology & Oncology, May 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
7 X users
patent
3 patents

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
260 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
How to select IgG subclasses in developing anti-tumor therapeutic antibodies
Published in
Journal of Hematology & Oncology, May 2020
DOI 10.1186/s13045-020-00876-4
Pubmed ID
Authors

Jifeng Yu, Yongping Song, Wenzhi Tian

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 260 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 260 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 36 14%
Student > Bachelor 30 12%
Student > Ph. D. Student 28 11%
Student > Master 24 9%
Other 16 6%
Other 23 9%
Unknown 103 40%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 54 21%
Immunology and Microbiology 20 8%
Pharmacology, Toxicology and Pharmaceutical Science 19 7%
Agricultural and Biological Sciences 19 7%
Medicine and Dentistry 15 6%
Other 26 10%
Unknown 107 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 February 2024.
All research outputs
#3,604,239
of 25,605,018 outputs
Outputs from Journal of Hematology & Oncology
#316
of 1,299 outputs
Outputs of similar age
#89,673
of 414,104 outputs
Outputs of similar age from Journal of Hematology & Oncology
#14
of 44 outputs
Altmetric has tracked 25,605,018 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,299 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 414,104 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.